Trucheck is a blood-based, non-invasive screening test for solid tumors that detects circulating tumor cells to enable early cancer detection. It offers multi-cancer options, such as Trucheck Intelli (up to 70 tumor types) and Trucheck FemmeSafe (breast, ovaries, uterus, cervix), designed for asymptomatic individuals and those at higher risk or undergoing annual screening. The platform provides tissue-of-origin information from the tumor, complements imaging, and integrates advanced genomic analysis, liquid biopsy approaches, and customized MRD solutions for solid organ cancers.
AI named Trucheck from June 2026 to September 2026.
None of these answers cited datarpgx.de. AI leaned on galleri.com, grail.com, and ncbi.nlm.nih.gov.
datarpgx.de/en/trucheck-en 0%Other sites 100%
Excerpts where Trucheck appeared in the AI's answer
Trucheck — available in some countries and uses circulating tumor cells